An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows

3 months ago 12
An experimental cause mightiness assistance dilatory aboriginal Alzheimer's illness successful a markedly antithetic mode than today's treatments—by lowering levels of a encephalon macromolecule called tau, researchers reported Tuesday.
Read Entire Article